Skip to main content
Clinical Trials/NCT05663346
NCT05663346
Completed
Not Applicable

Evaluation of a Digital Educational Intervention Regarding Safe and Efficient Cannabis Use with Young Adults Diagnosed with Cancer: a Pilot Study

Ciusss de L'Est de l'Île de Montréal1 site in 1 country70 target enrollmentJanuary 4, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cannabis Use
Sponsor
Ciusss de L'Est de l'Île de Montréal
Enrollment
70
Locations
1
Primary Endpoint
Change in self-efficacy
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to evaluate the preliminary effects and impacts of a digital educational intervention to support nurses' professional practice regarding safe cannabis use by young adults (18-39 years) diagnosed with cancer.

Detailed Description

This online pilot randomized controlled trial with parallel groups is conducted in Quebec (Canada). Moodle learning management system will be used to train nurses working in oncology. After accepting the conditions and consenting, participants will enroll in the study by providing an email address. Each participant will be validated through an email address check. After their enrolment, participants will receive a hyperlink via email to invite them to complete a baseline questionnaire. After completing the baseline questionnaire, participants will be randomly assigned by a research assistant to the digital educational intervention (Cannabis \& Cancer) or to a control group (official public websites and scientific articles). Four weeks after the baseline questionnaire, participants will complete the online questionnaires again.

Registry
clinicaltrials.gov
Start Date
January 4, 2024
End Date
May 18, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ciusss de L'Est de l'Île de Montréal
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Work in an oncology department (eg, radio-oncology, outpatient clinics)
  • Work with people diagnosed with cancer, including young adults
  • Understand, read, and write French

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in self-efficacy

Time Frame: 4 weeks

The French version of the Continuing Professional Development Reaction (CPD-Reaction) questionnaire (Légaré et al., 2014) will be used. The CPD-Reaction is a 12-item theory-based self-report questionnaire designed to assess the impact of continuing professional development on different clinical practices and can be modified according to the behavior targeted by the continuing professional activity (ie, the Cannabis \& Cancer intervention). It is scored using a seven-point Likert scale ranging from strongly disagree (1) to strongly agree (7). The total score can range from 3 to 21 for self-efficacy. Higher scores indicate higher levels of self-efficacy. The CPD Reaction has adequate test-retest reliability (ie, weighted kappa coefficient between 0.43-0.53 for self-efficacy). The questionnaire has good internal consistency (Cronbach's alpha = 0.84).

Secondary Outcomes

  • Frequency of viewing modules/participants (objective engagement)(4 weeks)
  • Time required to complete all training modules (objective engagement)(4 weeks)
  • Subjective engagement with the digital educational intervention(4 weeks)
  • Change in attitudes(4 weeks)
  • Change in knowledge(4 weeks)
  • Number of training modules completed by participants (objective engagement)(4 weeks)
  • Number of logins to the digital educational intervention/participant (objective engagement)(4 weeks)
  • Change in intention(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials